BeStock  
Stocks › Biotechnology › SRPT

Sarepta Therapeutics SRPT

US equityMarket cap rank #2908Biotechnology
$13.33 −$0.84 (-5.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.60 +2.03%
Open$13.92
Prev close$14.17
Day range$13.25 – $14.47
Volume2.25M
Market cap$1.43B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.5x
CheapRich

Around its usual level · 43rd percentile, 5-year average 23.6x

Price / book1.1x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average 10.2x

#1654 of 5330 stocks by PB (1 = cheapest)

Price / sales0.9x
CheapRich

Near the bottom of its 5-year range · 14th percentile, 5-year average 7.0x

#1550 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-96x72x240x409xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$19.79
Price vs. fair value-32.6%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.13 – 10.17 2% (cheaper than usual) #1654 of 5330 (1 = cheapest)
PE -12.46 -52.72 23.56 43% (cheaper than usual) –
PS 0.88 1.22 6.96 14% (cheaper than usual) #1550 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on SRPT.

Sign in to join the discussion.

Scroll to Top